For example, an anti-CCL1 monoclonal antibody ameliorated BLM- and hMSC-induced lung fibrosis in mice, and blockade of CCL3 with a monoclonal antibody or a CCL3-binding protein (evasin-1) attenuated PF in BLM mice. Here, CCL1 is linked to pulmonary fibrosis.